1-15767441-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_017556.4(FBLIM1):c.316C>T(p.Pro106Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000215 in 1,392,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017556.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBLIM1 | NM_017556.4 | c.316C>T | p.Pro106Ser | missense_variant | 4/9 | ENST00000375766.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBLIM1 | ENST00000375766.8 | c.316C>T | p.Pro106Ser | missense_variant | 4/9 | 2 | NM_017556.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 4AN: 148996Hom.: 0 Cov.: 25 FAILED QC
GnomAD3 exomes AF: 0.0000278 AC: 6AN: 215540Hom.: 0 AF XY: 0.0000424 AC XY: 5AN XY: 118050
GnomAD4 exome AF: 0.0000215 AC: 30AN: 1392970Hom.: 0 Cov.: 24 AF XY: 0.0000274 AC XY: 19AN XY: 694666
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000268 AC: 4AN: 149114Hom.: 0 Cov.: 25 AF XY: 0.0000275 AC XY: 2AN XY: 72684
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.316C>T (p.P106S) alteration is located in exon 3 (coding exon 2) of the FBLIM1 gene. This alteration results from a C to T substitution at nucleotide position 316, causing the proline (P) at amino acid position 106 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at